Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Dosing Comparison# BPC-157 Dosing# In preclinical research, BPC-157 has been studied across a range of administration routes: Subcutaneous injection : Typical research doses range from 200-800 mcg/day in human-equivalent calculations Oral administration : BPC-157 shows stability in gastric acid, with studies demonstrating oral bioavailability Local injection : Site-specific injection near injury areas has been used in tendon and ligament studies Intraperitoneal : Common route in rodent studies at doses of 10 mcg/kg to 10 ng/kg BPC-157 is typically reconstituted from lyophilized powder with bacteriostatic water for injection protocols
We typically respond to support inquiries within the same day
For greater trochanteric pain syndrome and gluteal tendinopathy, injecting subcutaneously over the lateral hip approximately 1 to 2 inches from the point of maximum tenderness provides local effects
Purity issues, degradation from improper storage during shipping, or incorrect reconstitution could all explain poor results
The rationale for combining them is that they may act through complementary repair pathways
.png)
US$ 24.87
US$ 24.33
US$ 26.68
US$ 25.01
US$ 21.98
